Loading...
iHuman Inc (IH) is not a strong buy for a beginner, long-term investor at this moment. The lack of significant positive catalysts, neutral trading sentiment, and declining financial performance outweigh the slight technical positivity. While the stock has a chance for a monthly gain, it is not compelling enough given the investor's profile and goals.
The MACD is positive but contracting, suggesting weakening momentum. RSI is neutral at 63.224, and moving averages are converging, indicating no strong trend. The stock is trading near its pivot point of 1.968 with resistance at 2.146 and support at 1.79.
EPS increased significantly by 344.44% YoY in Q3 2025.
Gross Margin slightly declined. No recent news or significant trading activity from insiders, hedge funds, or Congress.
In Q3 2025, revenue and net income declined significantly YoY, while EPS showed a sharp increase. Gross margin remained stable but slightly decreased.
No data on analyst ratings or price target changes.
